跳至主要内容
临床试验/NCT01777698
NCT01777698已完成不适用

Body Composition Analysis by Bioelectrical Impedance Vector Analysis in Patients With Hepatocellular Carcinoma Undergoing Chemoembolization.

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2012年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
21
试验地点
1
主要终点
Changes in body composition

研究概览

简要总结

Hepatocellular carcinoma represents 80-90% of primary hepatic malignant tumors. 80% of patients with hepatocellular carcinoma are associated with cirrhosis.

Chemoembolization is a process in which a chemotherapeutic agent is deposited directly into the hepatic tumor where the principal artery is embolized.

Bioelectrical impedance bases its evaluation in a model where the body is conformed by two different compartments: fat mass and fat free mass.

Bioelectrical impedance is complemented by vectorial analysis, which is independent to the state of hydration and is helpful to monitor any changes in corporal composition. It can be used as a control for the interpretation of the bioelectrical impedance.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with hepato-renal disease
  • •Patients with hepatocellular carcinoma that are put down to radiofrequency ablation
  • •Patients with depression or any psiquiatric disease.
  • •Patients that don't agree to participate in the project.

排除标准

  • •Patients with hepatocellular carcinoma that are put down to radiofrequency ablation
  • •Patients with depression or any psiquiatric disease.
  • •Patients that don't agree to participate in the project.

结局指标

主要结局

Changes in body composition

时间窗: 1 hour before treatment, 2 weeks after treatment, and 1 month after treatment

To evaluate any changes in corporal composition in patients undergoing chemoembolization.

次要结局

未报告次要终点

研究者

发起方
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
申办方类型
Other
责任方
Principal Investigator
主要研究者

ALDO TORRE DELGADILLO

M.D., M.Sc.

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

研究点 (1)

Loading locations...

相似试验